We served as lead counsel representing a national pharmaceutical ingredient supplier and its wholly-owned subsidiaries in an investigation of alleged False Claims Act (FCA) violations concerning inflated Average Wholesale Prices, kickbacks to physicians, and waivers of co-pays. After a several-year investigation based on the filing of four separate qui tams, we negotiated a successful resolution of the litigation that was far less than the government’s alleged damages of several hundred million dollars. Reported decision: U.S. ex rel. Hueseman v. PSI et al., (WDTX) and U.S. ex rel. Sten v. Midwest Compounders, et al., (NDIA).
Representation of Life Sciences Company Fagron Holding USA LLC
You Also May Be Interested In:
Representation of Spring Fertility, a premier provider of fertility care in the United States backed by Wildcat Capital, in its acquisition of Genesis Fertility Centre, a Vancouver, British Columbia-based fertility clinic
Representation of SCP Eye Care Services in its acquisition of Coastal Eye Associates, a comprehensive ophthalmology physician practice group based in Texas